# EDGAR Filing Document

**Accession Number:** 0001792267
**File Stem:** 0001193125-23-034064
**Filing Date:** 2023-2
**Character Count:** 32437
**Document Hash:** ccce9279658dcb140de143031f65f249
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-034064.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001193125-23-034064

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**GROUP MEMBERS**: CHINA MERCHANTS BANK CO., LTD

**GROUP MEMBERS**: CMB INTERNATIONAL CAPITAL HOLDINGS CORP LTD

**GROUP MEMBERS**: CMB INTERNATIONAL INVESTMENT MANAGEMENT LTD

**GROUP MEMBERS**: CMB INTERNATIONAL PRIVATE INVESTMENT LTD

**GROUP MEMBERS**: CMBI PRIVATE EQUITY SERIES SPC ON BEHALF OF & FOR THE ACCOUNT OF BIOTECHNOLOGY FUND IV SP

**GROUP MEMBERS**: EVERGREEN SERIESC LIMITED PARTNERSHIP

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Burning Rock Biotech Ltd
- **CENTRAL INDEX KEY:** 0001792267
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **IRS NUMBER:** 000000000

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92114
- **FILM NUMBER:** 23614565

**BUSINESS ADDRESS:**
- **STREET 1:** NO. 5 XINGDAO RING ROAD NORTH,
- **STREET 2:** INTERNATIONAL BIO ISLAND
- **CITY:** GUANGZHOU, GUANGDONG
- **STATE:** F4
- **ZIP:** 510005
- **BUSINESS PHONE:** 86 18501641666

**MAIL ADDRESS:**
- **STREET 1:** NO. 5 XINGDAO RING ROAD NORTH,
- **STREET 2:** INTERNATIONAL BIO ISLAND
- **CITY:** GUANGZHOU, GUANGDONG
- **STATE:** F4
- **ZIP:** 510005
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CMB International Capital Corp Ltd
- **CENTRAL INDEX KEY:** 0001844562
- **IRS NUMBER:** 000000000

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 46/F CHAMPION TOWER 3 GARDEN ROAD
- **CITY:** CENTRAL
- **STATE:** K3
- **ZIP:** 000000
- **BUSINESS PHONE:** 852-3900-0888

**MAIL ADDRESS:**
- **STREET 1:** 46/F CHAMPION TOWER 3 GARDEN ROAD
- **CITY:** CENTRAL
- **STATE:** K3
- **ZIP:** 000000

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**SCHEDULE 13G** 

**Under the Securities Exchange Act of 1934** 

**(Amendment No. 2)\*** 

------

## Burning Rock Biotech Limited
**(Name of Issuer)** 

**Class A Ordinary Shares, par value US$0.0002 per share** 

**(Titles of Class of Securities)** 

**G17173 108<sup>\*\*</sup>** 

**(CUSIP Number)** 

**December 31, 2022** 

**(Date of Event Which Requires Filing of this Statement)** 

------

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out of a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the "<u>Act</u>") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

\*\* This CUSIP number applies to the Class A ordinary shares ("<u>Class</u> <u>A Ordinary Shares</u>") of Burning Rock Biotech Limited (the "<u>Issuer</u>"). CUSIP number 12233L 107 applies to the American Depositary Shares ("<u>ADSs</u>") of the Issuer, each ADS representing one Class A Ordinary Share. 

------

---

| | | |
|:---|:---|:---|
| **CUSIP No. G17173 108** | **13G** | **Page 2 of 14** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;China Merchants Bank Co., Limited |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Hong Kong |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;8.0%\* |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CO |

---

\* Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. 

------

---

| | | |
|:---|:---|:---|
| **CUSIP No. G17173 108** | **13G** | **Page 3 of 14** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CMB International Capital Holdings Corporation Limited |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Hong Kong |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;8.0%\* |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CO |

---

\* Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. 

------

---

| | | |
|:---|:---|:---|
| **CUSIP No. G17173 108** | **13G** | **Page 4 of 14** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CMB International Capital Corporation Limited |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Hong Kong |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;8.0%\* |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CO |

---

\* Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 20-F filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. 

------

---

| | | |
|:---|:---|:---|
| **CUSIP No. G17173 108** | **13G** | **Page 5 of 14** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CMB International Investment Management Limited |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;British Virgin Islands |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;8.0%\* |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CO |

---

\* Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. 

------

---

| | | |
|:---|:---|:---|
| **CUSIP No. G17173 108** | **13G** | **Page 6 of 14** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CMB International Private Investment Limited |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Cayman Islands |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;7,017,385 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;8.0%\* |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CO |

---

\* Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. 

------

---

| | | |
|:---|:---|:---|
| **CUSIP No. G17173 108** | **13G** | **Page 7 of 14** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSONS<br>&nbsp;&nbsp;&nbsp;&nbsp;EverGreen SeriesC Limited Partnership |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Cayman Islands |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;5,964,435 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;5,964,435 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;5,964,435 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;6.8%\* |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;PN |

---

\* Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. 

------

---

| | | |
|:---|:---|:---|
| **CUSIP No. G17173 108** | **13G** | **Page 8 of 14** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAME OF REPORTING PERSONS<br>&nbsp;&nbsp;&nbsp;&nbsp;CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Cayman Islands |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;1,052,950 |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;- 0 - |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;1,052,950 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;1,052,950 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;1.2%\* |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;CO |

---

\* Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. 

------

---

| | |
|:---|:---|
| **Item 1(a).** | **Name of Issuer:**  |

---

Burning Rock Biotech Limited

---

| | |
|:---|:---|
| **Item 1(b).** | **Address of Issuer's Principal Executive Offices:**  |

---

No. 5, Xingdao Ring Road North

International Bio Island, Guangzhou, 510005

People's Republic of China

---

| | |
|:---|:---|
| **Item 2(a).** | **Name of Person Filing:**  |

---

China Merchants Bank Co., Limited

CMB International Capital Holdings Corporation Limited

CMB International Capital Corporation Limited

CMB International Investment Management Limited

CMB International Private Investment Limited

EverGreen SeriesC Limited Partnership

CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP

(each, a "<u>Reporting Person</u>" and, collectively, "<u>Reporting Persons</u>")

---

| | |
|:---|:---|
| **Item 2(b).** | **Address of Principal Business Office or, if none, Residence:**  |

---

The principal business address of each of the Reporting Persons is as follows:

c/o CMB International Capital Corporation Limited

46th Floor, Champion Tower, 3 Garden Road, Hong Kong

---

| | |
|:---|:---|
| **Item 2(c).** | **Citizenship:**  |

---

Hong Kong:

China Merchants Bank Co., Limited

CMB International Capital Holdings Corporation Limited

CMB International Capital Corporation Limited

British Virgin Islands:

CMB International Investment Management Limited

Cayman Islands:

CMB International Private Investment Limited

EverGreen SeriesC Limited Partnership

CMBI Private Equity Series SPC on behalf of and for the account of

Biotechnology Fund IV SP

---

| | |
|:---|:---|
| **Item 2(d).** | **Titles of Classes of Securities:**  |

---

Class A Ordinary Shares, par value US$0.0002 per share

Page 9 of 14

------

---

| | |
|:---|:---|
| **Item 2(e).** | **CUSIP Number:**  |

---

G17173 108\*

\* This CUSIP number applies to the Class A Ordinary Shares of the Issuer. CUSIP number 12233L 107 applies to the ADSs of the Issuer, each ADS representing one Class A Ordinary Share.

**Item 3.** **If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a(n):** <br>

---

| | |
|:---|:---|
| (a) | ☐ Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o). |
| (b) | ☐ Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c). |
| (c) | ☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c). |
| (d) | ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). |
| (e) | ☐ Investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). |
| (f) | ☐ Employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F). |
| (g) | ☐ Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). |
| (h) | ☐ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (13 U.S.C. 1813). |
| (i) | ☐ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3). |
| (j) | ☐ Non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J). |
| (k) | ☐ Group in accordance with §240.13d-1(b)(1)(ii)(K). |
|  If filing as a non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J), please specify the type of institution: ______________ | If filing as a non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J), please specify the type of institution: ______________ |

---

Page 10 of 14

------

**Item 4.** **Ownership** <br>

The following information with respect to the beneficial ownership of the Issuer's Class A Ordinary Shares by each of the Reporting Persons is presented as of December 31, 2022:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Reporting Person** | **(a)**<br>**Amount<br>beneficially<br>owned<sup>(1)</sup>:** | **(b)<br>Percent<br>of<br>class<sup>(2):</sup>** | **(c) Number of shares as to which<br>the person has:** | **(c) Number of shares as to which<br>the person has:** | **(c) Number of shares as to which<br>the person has:** | **(c) Number of shares as to which<br>the person has:** |
| **Reporting Person** | **(a)**<br>**Amount<br>beneficially<br>owned<sup>(1)</sup>:** | **(b)<br>Percent<br>of<br>class<sup>(2):</sup>** | **(i) Sole<br>power<br>to vote<br>or to<br>direct<br>the vote** | **(ii)**<br>**Shared<br>power to<br>vote or to<br>direct the<br>vote<sup>(1)</sup>** | **(iii) Sole<br>power to<br>dispose or<br>to direct<br>the<br>disposition<br>of** | **(iv) Shared<br>power to<br>dispose or<br>direct the<br>disposition<br>of<sup>(1)</sup>** |
|  China Merchants Bank Co., Limited | 7017385 | 8.0% | 0 | 7017385 | 0 | 7017385 |
|  CMB International Capital Holdings Corporation Limited | 7017385 | 8.0% | 0 | 7017385 | 0 | 7017385 |
|  CMB International Capital Corporation Limited | 7017385 | 8.0% | 0 | 7017385 | 0 | 7017385 |
|  CMB International Investment Management Limited | 7017385 | 8.0% | 0 | 7017385 | 0 | 7017385 |
|  CMB International Private Investment Limited | 7017385 | 8.0% | 0 | 7017385 | 0 | 7017385 |
|  EverGreen SeriesC Limited Partnership | 5964435 | 6.8% | 0 | 5964435 | 0 | 5964435 |
|  CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP | 1052950 | 1.2% | 0 | 1052950 | 0 | 1052950 |

---

(1) EverGreen SeriesC Limited Partnership (" <u>EverGreen</u> "), a Cayman Islands exempted limited
partnership, directly holds 5,964,435 Class A Ordinary Shares (including 3,829,927 Class A Ordinary Shares in the form of ADSs). CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP
(" <u>SPC</u> "), a segregated portfolio company incorporated under the laws of the Cayman Islands, directly holds 1,052,950 Class A Ordinary Shares (including 800,000 Class A Ordinary Shares in the form of ADSs).

CMB International Private Investment Limited ("<u>CMBIPI</u>"), a company incorporated under the laws of Cayman Islands, is the general partner of EverGreen and owns all the management shares of SPC. CMBIPI is wholly owned by CMB International Investment Management Limited ("<u>CMBIIM</u>"), a company incorporated under the laws of the British Virgin Islands. CMBIIM is wholly owned by CMB International Capital Corporation Limited ("<u>CMBICC</u>"), a company incorporated in Hong Kong. CMBICC is a majority owned subsidiary of CMB International Capital Holdings Corporation Limited ("<u>CMBICH</u>"), a company incorporated in Hong Kong. CMBICH is wholly owned by China Merchants Bank Co., Limited ("<u>CMB</u>"), a company incorporated in Hong Kong and listed on the Stock Exchange of Hong Kong. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, each of CMBIPI, CMBIIM, CMBICC, CMBICH and CMB may be deemed to beneficially own all of the Issuer's shares held by EverGreen and SPC.

Page 11 of 14

------

(2) Calculated based on the number of Class A Ordinary Shares beneficially owned by each of the Reporting
Persons as of December 31, 2022, divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on
November 7, 2022.

**Item 5.** **Ownership of Five Percent or Less of a Class.** <br>

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

**Item 6.** **Ownership of More than Five Percent on Behalf of Another Person.** <br>

Not Applicable.

**Item 7.** **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.** <br>

Not Applicable.

**Item 8.** **Identification and Classification of Members of the Group.** <br>

Not Applicable.

**Item 9.** **Notice of Dissolution of Group.** <br>

Not Applicable.

**Item 10.** **Certification.** <br>

Not Applicable.

Page 12 of 14

------

**<u>Exhibit Index</u>**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | Joint Filing Agreement |

---

Page 13 of 14

------

**<u>SIGNATURE</u>**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2023

---

| | |
|:---|:---|
| **CHINA MERCHANTS BANK CO., LIMITED** | **CHINA MERCHANTS BANK CO., LIMITED** |
| By: | /s/ Liang Wang |
| Name: Liang Wang | Name: Liang Wang |
| Title: Director | Title: Director |
| **CMB INTERNATIONAL CAPITAL HOLDINGS CORPORATION LIMITED** | **CMB INTERNATIONAL CAPITAL HOLDINGS CORPORATION LIMITED** |
| By: | /s/ Liang Wang |
| Name: Liang Wang | Name: Liang Wang |
| Title: Director | Title: Director |
| **CMB INTERNATIONAL CAPITAL CORPORATION LIMITED** | **CMB INTERNATIONAL CAPITAL CORPORATION LIMITED** |
| By: | /s/ Ju Zhao |
| Name: Ju Zhao | Name: Ju Zhao |
| Title: Director | Title: Director |
| **CMB INTERNATIONAL INVESTMENT MANAGEMENT LIMITED** | **CMB INTERNATIONAL INVESTMENT MANAGEMENT LIMITED** |
| By: | /s/ Yiwen Gao |
| Name: Yiwen Gao | Name: Yiwen Gao |
| Title: Director | Title: Director |
| **CMB INTERNATIONAL PRIVATE INVESTMENT LIMITED** | **CMB INTERNATIONAL PRIVATE INVESTMENT LIMITED** |
| By: | /s/ Rongfeng Jiang |
| Name: Rongfeng Jiang | Name: Rongfeng Jiang |
| Title: Director | Title: Director |
| **EVERGREEN SERIESC LIMITED PARTNERSHIP** | **EVERGREEN SERIESC LIMITED PARTNERSHIP** |
| By: | CMB International Private Investment Limited, its general partner |
| By: | /s/ Rongfeng Jiang |
| Name: Rongfeng Jiang | Name: Rongfeng Jiang |
| Title: Director | Title: Director |

---

---

| | |
|:---|:---|
| **CMBI PRIVATE EQUITY SERIES SPC ON BEHALF OF AND FOR THE ACCOUNT OF BIOTECHNOLOGY FUND IV SP** | **CMBI PRIVATE EQUITY SERIES SPC ON BEHALF OF AND FOR THE ACCOUNT OF BIOTECHNOLOGY FUND IV SP** |
| By: | /s/ Rongfeng Jiang |
| Name: Rongfeng Jiang | Name: Rongfeng Jiang |
| Title: Director | Title: Director |

---

Page 14 of 14

## Exhibit 99.1

**EXHIBIT 99.1** 

**Joint Filing Agreement** 

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A ordinary shares, par value of $0.0002 per share, of Burning Rock Biotech Limited, and that this agreement may be included as an exhibit to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

[*Signature page to follow*]

------

IN WITNESS WHEREOF, the undersigned hereby execute this agreement as of February 13, 2023.

---

| | |
|:---|:---|
| **CHINA MERCHANTS BANK CO., LIMITED** | **CHINA MERCHANTS BANK CO., LIMITED** |
| By: | /s/ Liang Wang |
| Name: | Liang Wang |
| Title: | Director |
| **CMB INTERNATIONAL CAPITAL HOLDINGS CORPORATION LIMITED** | **CMB INTERNATIONAL CAPITAL HOLDINGS CORPORATION LIMITED** |
| By: | /s/ Liang Wang |
| Name: | Liang Wang |
| Title: | Director |
| **CMB INTERNATIONAL CAPITAL CORPORATION LIMITED** | **CMB INTERNATIONAL CAPITAL CORPORATION LIMITED** |
| By: | /s/ Ju Zhao |
| Name: | Ju Zhao |
| Title: | Director |
| **CMB INTERNATIONAL INVESTMENT MANAGEMENT LIMITED** | **CMB INTERNATIONAL INVESTMENT MANAGEMENT LIMITED** |
| By: | /s/ Yiwen Gao |
| Name: | Yiwen Gao |
| Title: | Director |
| **CMB INTERNATIONAL PRIVATE INVESTMENT LIMITED** | **CMB INTERNATIONAL PRIVATE INVESTMENT LIMITED** |
| By: | /s/ Rongfeng Jiang |
| Name: | Rongfeng Jiang |
| Title: | Director |
| **EVERGREEN SERIESC LIMITED PARTNERSHIP** | **EVERGREEN SERIESC LIMITED PARTNERSHIP** |
| By: | CMB International Private Investment Limited, its general partner |
| By: | /s/ Rongfeng Jiang |
| Name: | Rongfeng Jiang |
| Title: | Director |
| **CMBI PRIVATE EQUITY SERIES SPC ON BEHALF OF AND FOR THE ACCOUNT OF BIOTECHNOLOGY FUND IV SP** | **CMBI PRIVATE EQUITY SERIES SPC ON BEHALF OF AND FOR THE ACCOUNT OF BIOTECHNOLOGY FUND IV SP** |
| By: | /s/ Rongfeng Jiang |
| Name: | Rongfeng Jiang |
| Title: | Director |

---

[*Signature Page to Joint Filing Agreement*]